Serum level of specific IgG antibody for aspergillus and its association with severity of asthma in asthmatic children Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases Year: 2012
Serum IgG and IgA antibodies to chramydia pneumoniae and severity of emphysema Source: Eur Respir J 2004; 24: Suppl. 48, 44s Year: 2004
The importance of quantifying serum antibody associated with allergic alveolitis Source: Eur Respir J 2004; 24: Suppl. 48, 355s Year: 2004
MEMP1972A, an anti-M1 prime monoclonal antibody, reduces serum IgE in healthy and allergic rhinitis subjects Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012
High prevalence of serum IgA antibodies against gliadin in patients with interstitial lung diseases confirmed by immunoblotting Source: Eur Respir J 2003; 22: Suppl. 45, 227s Year: 2003
Specific IgG antibodies in chronic hypersensitivity pneumonitis Source: International Congress 2015 – IIPs: orphan Year: 2015
Age is a predictor of efficacy of monoclonal antibodies in allergic severe asthma Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019
Effects of anti-M1 prime monoclonal antibody, MEMP1972A following allergen challenge in patients with mild asthma Source: Annual Congress 2012 - New bronchodilators and other novel drugs for asthma and COPD Year: 2012
Diagnostic value of serum precipitins to mould antigens in active hypersensitivity pneumonitis Source: Eur Respir J 2007; 29: 706-712 Year: 2007
Study to determine reference ranges for specific serum IgG against antigens implicated in hypersensitivity pneumonitis in Singapore Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017
Determining early response to anti-IL5/IL5R monoclonal antibodies in severe eosinophilic asthma Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020
Specific serum immunoglobulins G (IgGs) may serve as pointers towards inhalation antigen exposure in patients with hypersensitivity pneumonitis (HP) and uncertain exposure source. Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019
Serum anti DFS70 antibody titer and lung functional impairment in patients with interstitial lung disease (ILD) Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017
An association between sarcoidosis and serum immunoglobulin levels Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020
Treatment with omalizumab (rhuMAb-E25), a monoclonal anti-IgE antibody induces effective changes in subjects with allergic asthma Source: Eur Respir J 2001; 18: Suppl. 33, 37s Year: 2001
The relationship between total IgE and specific antibody testing by Immunocap in screening allergic asthma Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020
Evaluation of bronchial hyperreactivity and other functional parameters in severe asthma patients treated with anti-interleukin-5 monoclonal antibody (IL5) Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019
Suboptimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena Source: Eur Respir J, 56 (4) 2000117; 10.1183/13993003.00117-2020 Year: 2020
Subcutaneuous injection of monoclonal antibody anti-DEC205 conjugated with ovalbumin atenuates allergic lung inflammation of animals previously sensitized to allergen Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012
Change of lung function in severe eosinophilic asthma undergoing treatment with anti-interleukin-5 monoclonal antibody Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018